• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GPR87在膀胱尿路上皮癌中的表达及作用

Expression and role of GPR87 in urothelial carcinoma of the bladder.

作者信息

Okazoe Homare, Zhang Xia, Liu Dage, Shibuya Shinsuke, Ueda Nobufumi, Sugimoto Mikio, Kakehi Yoshiyuki

机构信息

Department of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.

出版信息

Int J Mol Sci. 2013 Jun 10;14(6):12367-79. doi: 10.3390/ijms140612367.

DOI:10.3390/ijms140612367
PMID:23752273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3709790/
Abstract

The orphan GPR87 has recently been matched with its ligand LPA, which is a lipid mediator with multiple physiological functions, including cancer cell proliferation. This study aimed to clarify the role of GPR87 in urothelial carcinoma of the bladder. GPR87 expression was assessed in seven human bladder cancer cell lines. A replication-deficient recombinant adenoviral vector expressing shRNA targeting GPR87 (Ad-shGPR87), was constructed. Gene silencing was carried out using Ad-shGPR87. Immunohistochemical analysis was performed for transurethral resection of bladder tumor samples from 71 patients with non-muscle-invasive bladder cancer. We observed GPR87 expression in five of the seven cell lines, and silencing GPR87 gene expression significantly reduced cell viability. GPR87 expression was positive in 38 (54%) of 71 tumors. Ki-67 index was associated with positive GPR87 staining status (p < 0.0001). Patients with GPR87-positive tumors had shorter intravesical recurrence-free survival than those with GPR87-negative tumors (p = 0.010). Multivariate analysis revealed that GPR87 staining status was an independent prognostic parameter for intravesical recurrence (p = 0.041). Progression from non-muscle-invasive to muscle-invasive tumor was more frequently observed in patients with GPR87-positive tumors, although this trend did not reach statistical significance (p = 0.056). These results warrant further prospective studies to clarify the role of GPR87 expression in intravesical recurrence and progression in bladder cancer.

摘要

孤儿G蛋白偶联受体87(GPR87)最近被发现与它的配体溶血磷脂酸(LPA)相匹配,LPA是一种具有多种生理功能的脂质介质,包括癌细胞增殖。本研究旨在阐明GPR87在膀胱尿路上皮癌中的作用。对七种人膀胱癌细胞系中的GPR87表达进行了评估。构建了一种表达靶向GPR87的短发夹RNA(shRNA)的复制缺陷型重组腺病毒载体(Ad-shGPR87)。使用Ad-shGPR87进行基因沉默。对71例非肌层浸润性膀胱癌患者的膀胱肿瘤经尿道切除标本进行免疫组织化学分析。我们在七种细胞系中的五种中观察到GPR87表达,并且沉默GPR87基因表达显著降低了细胞活力。71例肿瘤中有38例(54%)GPR87表达呈阳性。Ki-67指数与GPR87染色阳性状态相关(p<0.0001)。GPR87阳性肿瘤患者的膀胱内无复发生存期比GPR87阴性肿瘤患者短(p = 0.010)。多变量分析显示,GPR87染色状态是膀胱内复发的独立预后参数(p = 0.041)。在GPR87阳性肿瘤患者中更频繁地观察到从非肌层浸润性肿瘤进展为肌层浸润性肿瘤,尽管这一趋势未达到统计学显著性(p = 0.056)。这些结果需要进一步的前瞻性研究来阐明GPR87表达在膀胱癌膀胱内复发和进展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/3709790/1954791da2d1/ijms-14-12367f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/3709790/59542d54d038/ijms-14-12367f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/3709790/36ed369f82db/ijms-14-12367f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/3709790/9f7cc5604ff1/ijms-14-12367f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/3709790/1954791da2d1/ijms-14-12367f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/3709790/59542d54d038/ijms-14-12367f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/3709790/36ed369f82db/ijms-14-12367f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/3709790/9f7cc5604ff1/ijms-14-12367f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6064/3709790/1954791da2d1/ijms-14-12367f5.jpg

相似文献

1
Expression and role of GPR87 in urothelial carcinoma of the bladder.GPR87在膀胱尿路上皮癌中的表达及作用
Int J Mol Sci. 2013 Jun 10;14(6):12367-79. doi: 10.3390/ijms140612367.
2
G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells.G蛋白偶联受体87(GPR87)促进人膀胱癌细胞的增殖。
Int J Mol Sci. 2015 Oct 14;16(10):24319-31. doi: 10.3390/ijms161024319.
3
Inhibition of Cell-surface Molecular GPR87 With GPR87-suppressing Adenoviral Vector Disturb Tumor Proliferation in Lung Cancer Cells.用抑制 GPR87 的腺病毒载体抑制 GPR87 抑制肺癌细胞中的肿瘤增殖。
Anticancer Res. 2020 Feb;40(2):733-741. doi: 10.21873/anticanres.14004.
4
Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.膀胱非肌层浸润性尿路上皮癌中上皮-间质转化标志物的表达谱:与经尿道切除术后膀胱内复发的相关性
Urol Oncol. 2015 Mar;33(3):110.e11-8. doi: 10.1016/j.urolonc.2014.08.012. Epub 2014 Sep 26.
5
Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway.G蛋白偶联受体GPR87的过表达促进胰腺癌的侵袭性并激活核因子κB信号通路。
Mol Cancer. 2017 Mar 14;16(1):61. doi: 10.1186/s12943-017-0627-6.
6
Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.卡介苗膀胱灌注治疗浅表性膀胱肿瘤患者中p53、p21WAF1/CIP1和Ki-67表达的相关性及预后意义
J Urol. 1999 Mar;161(3):792-8.
7
Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification.Ki-67指数提高了尿路上皮浅表性膀胱癌风险组分类的预后准确性。
Int J Cancer. 2003 Jun 10;105(2):267-72. doi: 10.1002/ijc.11049.
8
GPR87 mediates lysophosphatidic acid-induced colony dispersal in A431 cells.GPR87 介导溶血磷脂酸诱导的 A431 细胞集落离散。
Eur J Pharmacol. 2013 Sep 5;715(1-3):15-20. doi: 10.1016/j.ejphar.2013.06.029. Epub 2013 Jul 4.
9
Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.内皮素轴在非浸润性和表浅性膀胱癌中的表达:与临床病理和分子预后参数的关系。
Eur Urol. 2009 Nov;56(5):837-45. doi: 10.1016/j.eururo.2008.10.003. Epub 2008 Oct 11.
10
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.再次经尿道膀胱肿瘤切除术(re-cTURBT)作为pT1期高级别(HG)疾病复发和进展的风险指标是否有用?一项单中心经验。
Arch Ital Urol Androl. 2017 Dec 31;89(4):272-276. doi: 10.4081/aiua.2017.4.272.

引用本文的文献

1
The path of GPR87: from a P2Y-like receptor to its role in cancer progression.GPR87的研究路径:从类P2Y受体到其在癌症进展中的作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4803-4815. doi: 10.1007/s00210-024-03684-6. Epub 2024 Dec 6.
2
Near-infrared photoimmunotherapy targeting GPR87: Development of a humanised anti-GPR87 mAb and therapeutic efficacy on a lung cancer mouse model.近红外光免疫疗法靶向 GPR87:人源化抗 GPR87 mAb 的开发及在肺癌小鼠模型中的治疗效果。
EBioMedicine. 2021 May;67:103372. doi: 10.1016/j.ebiom.2021.103372. Epub 2021 May 13.
3
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.

本文引用的文献

1
Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.溶血磷脂酸受体增强肝癌细胞的侵袭能力。
J Int Med Res. 2013 Feb;41(1):55-63. doi: 10.1177/0300060512474124. Epub 2013 Jan 23.
2
Lysophosphatidic acid is a modulator of cyst growth in autosomal dominant polycystic kidney disease.溶血磷脂酸是常染色体显性多囊肾病中囊肿生长的调节剂。
Cell Physiol Biochem. 2011;28(6):1255-64. doi: 10.1159/000335857. Epub 2011 Dec 16.
3
LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
溶血磷脂酸及其受体在健康和疾病中的作用:新的治疗策略。
Signal Transduct Target Ther. 2021 Feb 1;6(1):45. doi: 10.1038/s41392-020-00367-5.
4
G Protein-Coupled Receptor GPR87 Promotes the Expansion of PDA Stem Cells through Activating JAK2/STAT3.G蛋白偶联受体GPR87通过激活JAK2/STAT3促进胰腺导管腺癌干细胞的扩增。
Mol Ther Oncolytics. 2020 Jan 28;17:384-393. doi: 10.1016/j.omto.2020.01.006. eCollection 2020 Jun 26.
5
Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis.Ki-67在非肌层浸润性膀胱癌患者中的意义:一项系统评价和荟萃分析。
Oncotarget. 2017 Oct 13;8(59):100614-100630. doi: 10.18632/oncotarget.21899. eCollection 2017 Nov 21.
6
High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.高Ki-67免疫组化反应性与膀胱癌预后不良相关:一项纳入13053例患者的综合荟萃分析。
Medicine (Baltimore). 2016 Apr;95(15):e3337. doi: 10.1097/MD.0000000000003337.
7
Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.脂质G蛋白偶联受体的靶点识别分子机制:与癌症的相关性
Oncogene. 2016 Aug 4;35(31):4021-35. doi: 10.1038/onc.2015.467. Epub 2015 Dec 7.
8
G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells.G蛋白偶联受体87(GPR87)促进人膀胱癌细胞的增殖。
Int J Mol Sci. 2015 Oct 14;16(10):24319-31. doi: 10.3390/ijms161024319.
9
Overexpression of G protein-coupled receptor 87 correlates with poorer tumor differentiation and higher tumor proliferation in non-small-cell lung cancer.G蛋白偶联受体87的过表达与非小细胞肺癌中较差的肿瘤分化和较高的肿瘤增殖相关。
Mol Clin Oncol. 2014 Jul;2(4):539-544. doi: 10.3892/mco.2014.292. Epub 2014 May 15.
LPA 受体与 CD97 形成异二聚体,以放大 LPA 起始的 RHO 依赖性信号转导并促进前列腺癌细胞浸润。
Cancer Res. 2011 Dec 1;71(23):7301-11. doi: 10.1158/0008-5472.CAN-11-2381. Epub 2011 Oct 6.
4
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.EAU 指南:非肌层浸润性膀胱尿路上皮癌,2011 年更新版。
Eur Urol. 2011 Jun;59(6):997-1008. doi: 10.1016/j.eururo.2011.03.017. Epub 2011 Mar 22.
5
Expression of autotaxin and acylglycerol kinase in prostate cancer: association with cancer development and progression.自分泌运动因子和酰基甘油激酶在前列腺癌中的表达:与癌症发生发展的关联
Cancer Sci. 2009 Sep;100(9):1631-8. doi: 10.1111/j.1349-7006.2009.01234.x. Epub 2009 May 31.
6
Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.前列腺中溶血磷脂酸相关分子的基因表达谱:与前列腺癌和良性增生的相关性。
Prostate. 2009 Feb 15;69(3):283-92. doi: 10.1002/pros.20879.
7
hGPR87 contributes to viability of human tumor cells.人GPR87对人肿瘤细胞的生存能力有贡献。
Int J Cancer. 2008 May 1;122(9):2008-16. doi: 10.1002/ijc.23349.
8
GPR87 is an overexpressed G-protein coupled receptor in squamous cell carcinoma of the lung.GPR87是一种在肺鳞状细胞癌中过表达的G蛋白偶联受体。
Dis Markers. 2008;24(1):41-50. doi: 10.1155/2008/857474.
9
The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor.孤儿G蛋白偶联受体GPR87的功能已被明确,它是一种溶血磷脂酸受体。
Biochem Biophys Res Commun. 2007 Nov 23;363(3):861-6. doi: 10.1016/j.bbrc.2007.09.063. Epub 2007 Sep 24.
10
G-protein-coupled receptors and cancer.G蛋白偶联受体与癌症。
Nat Rev Cancer. 2007 Feb;7(2):79-94. doi: 10.1038/nrc2069.